|
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies |
|
|
|
Title: |
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies |
Author: |
Mendzelevski, Boaz Ferber, Georg Janku, Filip Li, Bob T. Sullivan, Ryan J. Welsch, Dean Chi, Wei Jackson, Jeanne Weng, Onglee Sager, Philip T. |
Appeared in: |
Cancer, chemotherapy and pharmacology |
Paging: |
Volume 81 (2018) nr. 6 pages 1129-1141 |
Year: |
2018 |
Contents: |
|
Publisher: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|